CD8A and head and neck squamous cell carcinoma: Similarly, Balermpas et al. [17], in a study including different HNSCC locations (but only seven LSCC) found that a high CD3+ and CD8+ expression in pretreatment biopsies of patients that received definitive chemoradiotherapy was associated with a higher OS and DFS.